Skip to main content

Share

PHM Public Pharma Campaign

CILAC Brazil 2026 Forum: PHM Promotes Health Innovation and Public Production of Medicines

The People's Health Movement (PHM) and its Public Pharmaceuticals working group in Latin America will participate in the 5th Open Forum on Science in Latin America and the Caribbean (CILAC 2026), to be held November 24–26 in Brasília, Brazil, with the event “Public Pharma Design Sprint: Co-creating Policies to Democratize Health Innovation.”

At this event, the PHM will facilitate a space for discussion and co-creation aimed at democratizing health innovation and promoting public production of medicines. The Public Pharma Design Sprint hopes to bring together social organizations, movements for the right to health, universities, public institutions, and other stakeholders in Brasília to develop public policy proposals aimed at strengthening health sovereignty in Latin America and the Caribbean.

Who decides which health technologies are researched and developed? What interests guide the production of medicines and other health technologies? How can we strengthen public capacities and regional cooperation so that science and innovation respond to the needs of the people?

These questions are part of the challenges facing Latin America and the Caribbean regarding health sovereignty and the democratization of knowledge. In a context where the research, development, and production of health technologies are heavily influenced by market dynamics and the concentration of scientific, technological, and productive capacities, it is a priority to advance alternatives that strengthen the role of the public sector and democratic participation in decisions regarding health innovation.

This event offers a space for collective work to exchange experiences, identify existing capabilities, and develop concrete proposals that contribute to strengthening a regional agenda for science, technology, and innovation in health focused on the common good.

Event Information

Public Pharma Design Sprint: Co-creating Policies to Democratize Health Innovation

  • Date: Tuesday, November 24, 2026.
  • Time: 11:30 a.m. to 1:30 p.m.
  • Location: Ida Holz Room (formerly Geneva), Windsor Plaza Hotel, Brasília, Brazil.


Who is this event for?

Civil society organizations, movements for the right to health, universities, researchers, public institutions, public producers of health technologies, and all individuals and groups interested in health sovereignty, public production, and the democratization of science and innovation in health.

Please express your intention to participate by filling out this form: https://docs.google.com/forms/d/e/1FAIpQLScc1FFJOqCz2V_jCNxoIqTbVvlgD6S8e_r-3qmq9FoTVA59Lg/viewform

Let’s meet in Brasília to collectively build a regional agenda for science, technology, and innovation in health that serves the people!

 

Public Pharma: A Commitment to Democratizing Science and Innovation in Health

Public Pharma is an initiative launched by the Movement for People’s Health that seeks to contribute to the transformation of systems for the research, development, production, and distribution of health technologies, placing their public nature and their focus on social needs at the center of decision-making.

Its approach is based on the recognition that medicines, vaccines, diagnostics, medical devices, and other health technologies are essential to guaranteeing the right to health; therefore, their development and availability cannot depend exclusively on commercial interests or market profit dynamics.

From this perspective, Public Pharma proposes strengthening public capacities for research, development, and production; promoting international and regional cooperation; and expanding civil society’s participation in defining scientific and technological priorities. The goal is to move toward models of innovation that recognize knowledge as a common good and that respond to the needs of populations, especially those facing the greatest barriers to accessing health technologies.

This approach also highlights the need to strengthen coordination among governments, universities, research centers, public producers of health technologies, and social organizations. Building domestic capacities and mechanisms for cooperation among countries in the region is a central component of advancing toward greater health sovereignty.

CILAC 2026: From Discussion to Developing Proposals

The People's Health Movement’s participation in CILAC 2026 represents an opportunity to bring these debates to a regional forum where stakeholders in science, technology, and innovation can come together.

In particular, the “Public Pharma Design Sprint” event aims to foster dialogue among different sectors and experiences to address a common challenge: how to translate the principles of the democratization of science and innovation into public policies, cooperation mechanisms, and concrete actions for Latin America and the Caribbean.

Unlike a space focused exclusively on exhibitions or presentations, the activity will take the form of a public policy innovation clinic, based on an intensive co-creation methodology. The process will combine the exchange of knowledge, collective problem-solving, and collaborative work, drawing on principles of popular health education.

The proposal recognizes that the development of public policies cannot be limited to technical or institutional knowledge. It must also incorporate the experiences of local communities, the lessons learned by social organizations and movements for the right to health, as well as the capabilities of universities, research centers, and public institutions.

For the People's Health Movement, this process represents an opportunity to broaden the discussion on health sovereignty and strengthen the participation of social movements and civil society organizations in developing alternatives for systems of research, development, and production of health technologies.

The democratization of science and innovation in health requires public capacity, cooperation among peoples, and social participation in decisions that determine how knowledge is produced and for whom it is developed. CILAC 2026 will serve as a platform to advance this discussion and develop collective proposals that contribute to placing science, technology, and innovation at the service of the right to health and life.

 

 

 

 

Mostrar en principal
Off
Noticia Secundaria
Off